Drug Updates

Subcategories:Analgesics Biologics/DMARDs

Autoimmune Myelofibrosis: A Case Review

Mell Gutarra-Arana, MD; Theniat Haider, MD; Theodore Kieffer, MD; & Steven Hugenberg, MD | August 1, 2014

Diagnosis, treatment and management of AMF in Hispanic patient with lupus

Rheumatology Drug Updates, Trials, Safety Data

Michele B. Kaufman, PharmD, BCGP | July 1, 2014

An update on baricitinib, plus safety warnings on belimumab,
eszopiclone and zoledronic acid

Lupus Classification Criteria Expanded; Treat-to-Target Approach Gains Support

Gretchen Henkel | July 1, 2014

Rheumatologists at the California Rheumatology Alliance 10th Annual Medical & Scientific Meeting in San Francisco outline disease classification criteria, treat-to-target approach to lupus

Janus Kinase Inhibitors Represent New Tool to Slow Rheumatoid Arthritis

Gretchen Henkel | July 1, 2014

Physicians at the California Rheumatology Alliance 10th Annual Medical & Scientific Meeting in San Francisco report on studies about JAK inhibitors as targeted immunomodulators and disease-modifying therapies in RA

The 2014 ACR/ARHP Annual Meeting Offers Programs for Rheumatology Clinicians, Researchers, Practice Management Professionals

Staff | July 1, 2014

Rheumatology’s premier event to be held in Boston from Nov. 14–19

Malignant Atrophic Papulosis Is Challenging to Diagnose, Treat

Aixa Toledo-Garcia, MD, Jessica Farrell, PharmD, & Lee Shapiro, MD | July 1, 2014

Patient histories, clinician reports of condition also called Köhlmeier-Degos disease underscore need for integrated, multidisciplinary care

Rheumatology Drug Updates, Trials, Safety Data

Michele B. Kaufman, PharmD, BCGP | June 1, 2014

Legislative news on biosimilars, safety warning on epidural corticosteroid injections, and other drug updates rheumatologists need to know

What’s New in Inflammatory Arthritis?

Thomas R. Collins | June 1, 2014

Rheumatology experts at the ACR’s State-of-the-Art Clinical Symposium in Chicago discuss latest drug therapies, insights into axial spondyloarthritis and bone erosion, repair

New Osteoporosis Drugs Show Promise in Therapy Pipeline

Thomas R. Collins | June 1, 2014

Rheumatologists at the ACR’s State-of-the-Art Clinical Symposium in Chicago discuss medication alternatives to bisphosphonates that reduce bone resorption, build bone density and may provide new treatment options

How Rheumatologists Can Connect with Congressional Lawmakers during August Recess

Staff | June 1, 2014

Tips on scheduling in-office meetings in legislators’ home districts and which issues to discuss